Collectins and collectin receptors in innate immunity

APMIS, Supplement

Volumn 108, Issue 100, 2000, Pages 5-59

  Holmskov, U L ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CARBOHYDRATE; CARBOHYDRATE BINDING PROTEIN; COLLECTIN; COLLECTIN RECEPTOR; COMPLEMENT COMPONENT C3; CONGLUTININ; LECTIN; MANNAN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; CALRETICULIN; CARRIER PROTEIN; RIBONUCLEOPROTEIN;

ALLERGIC REACTION; ANTIGEN BINDING; AUTOIMMUNE DISEASE; BACTERIUM; CATTLE DISEASE; COMPLEMENT ACTIVATION; FUNGUS; IMMUNITY; IMMUNOCYTOCHEMISTRY; IMMUNOMODULATION; IMMUNOSURVEILLANCE; INFECTION SENSITIVITY; LEUKOCYTE; MOLECULAR RECOGNITION; PARASITE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TISSUE DISTRIBUTION; VIRUS; AMINO ACID SEQUENCE; ANIMAL; CARBOHYDRATE METABOLISM; CELL ADHESION; CHEMISTRY; COMMUNICABLE DISEASE; GENETICS; HEALTH; HUMAN; IMMUNOLOGY; IMMUNOPATHOLOGY; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; PARASITOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM-BINDING PROTEINS; CALRETICULIN; CARBOHYDRATE METABOLISM; CARBOHYDRATES; CARRIER PROTEINS; CELL ADHESION; COLLECTINS; COMMUNICABLE DISEASES; HEALTH; HUMANS; IMMUNE SYSTEM DISEASES; LECTINS; MOLECULAR SEQUENCE DATA; RIBONUCLEOPROTEINS;

EID: 0033650448     PISSN: 0903465X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (392)

1. Collectins: Pattern recognition molecules involved in first line host defence
2. Collectins: Collagenous C-type lectins of the innate immune defense system
3. Trimeric C-type lectin domains in host defence
4. Mannose-binding lectin: The pluripotent molecule of the innate immune system
5. The collectins in innate immunity
6. Pulmonary surfactant proteins
7. Potential role of surfactant proteins A and D in innate lung defense against pathogens
8. Immunomodulatory functions of surfactant
9. Structure, biologic properties, and expression of surfactant protein D (SP-D)
10. Biology of animal lectins
11. Evolution of Ca(2+)-dependent animal lectins
12. Structure of the calcium-dependent lectin domain from a rat mannose-binding protein determined by MAD phasing
13. Structure of a C-type mannose-binding protein complexed with an oligosaccharide
14. The immune system evolved to discriminate infectious nonself form noninfectious self
15. C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
16. Linkages of innate and adaptive immunity
17. Carbohydrate recognition systems: Functional triads in cell-cell interactions
18. Evolutionary conservation of intron position in a subfamily of genes encoding carbohydrate-recognition domains
19. Ficolins and the fibrinogen-like domain
20. Human ficolin: cDNA cloning, demonstration of peripheral blood leucocytes as the major site of synthesis and assignment of the gene to chromosome 9
21. Cloning and characterization of the human lectin P35 gene and its related gene
22. Two oligomeric forms of plasma ficolin have differential lectin activity
23. Structural aspects of collectins and receptors for collectins
24. Isolation and characterization of a mannan-binding protein from rabit liver
25. Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme Clr2Cls2 complex, of the classical pathway of complement, without involvement of Clq
26. Purification and characterization of bovine mannan-binding protein
27. Characterization of human surfactant-associated glycoprotein A
28. Bovine conglutinin is a collagen-like protein
29. Purification and characterization of a bovine serum lectin (CL-43) with structural homology to conglutinin and SP-D and carbohydrate specificity similar to mannan-binding protein
30. Purification and biochemical characterization of CP4 (SP-D), a collagenous surfactant-associated protein
31. A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins
32. Purification, characterization and cDNA cloning of human lung surfactant protein D
33. Characterization of a second human pulmonary surfactant-associated protein SP-A gene
34. Primary structure of bovine collectin-43 (CL-43). Comparison with conglutinin and lung surfactant protein-D
35. Affinity and kinetic analysis of the bovine plasma C-type lectin collectin-43 (CL-43) interacting with mannan
36. Structural characterization of bovine collectin-43
37. Molecular packing in collagen fibrils
38. Mannose-binding proteins isolated from rat liver contain carbohydrate-recognition domains linked to collagenous tails. Complete primary structures and homology with pulmonary surfactant apoprotein
39. Primary structure of rat liver mannan-binding protein deduced from its cDNA sequence
40. Molecular characterization of the mouse mannose-binding proteins. The mannose-binding protein A but not C is an acute phase reactant
41. cDNAs and deduced amino acid sequences of subunits in the binding component of mouse bactericidal factor, Ra-reactive factor: Similarity to mannose-binding proteins
42. Characterization of two mannose-binding protein cDNAs from rhesus monkey (Macaca mulatta): Structure and evolutionary implications
43. Cloning and characterization of a cDNA encoding bovine mannan-binding protein
44. Molecular and biological characterization of rabbit mannan-binding protein (MBP)
45. Cloning and sequencing of a cDNA encoding chicken mannan-binding lectin (MBL) and comparison with mammalian analogues
46. Primary structure of bovine conglutinin, a member of the C-type animal lectin family
47. The cDNA cloning of conglutinin and identification of liver as a primary site of synthesis of conglutinin in members of the Bovidae
48. Bovine conglutinin (BC) mRNA expressed in liver: Cloning and characterization of the BC cDNA reveals strong homology to surfactant protein-D
49. Cloning and sequencing of a cDNA coding for bovine conglutinin
50. Human surfactant protein D: SP-D contains a C-type lectin carbohydrate recognition domain
51. Structural similarity between bovine conglutinin and bovine lung surfactant protein D and demonstration of liver as a site of synthesis of conglutinin
52. Mouse surfactant protein-D. cDNA cloning, characterization, and gene localization to chromosome 14
53. Primary translation products of pulmonary surfactant protein D
54. Primary structure of rat pulmonary surfactant protein D. cDNA and deduced amino acid sequence
55. Isolation and characterization of cDNA clones for the 35-kDa pulmonary surfactant-associated protein
56. Structure of canine pulmonary surfactant apoprotein: cDNA and complete amino acid sequence
57. Transcriptional regulation of the gene encoding the major surfactant protein (SP-A) in rabbit fetal lung
58. Cloning of guinea pig surfactant protein A defines a distinct cellular distribution pattern within the lung
59. Murine pulmonary surfactant SP-A gene: Cloning, sequence, and transcriptional activity
60. Rat pulmonary surfactant protein A is expressed as two differently sized mRNA species which arise from differential polyadenylation of one transcript
61. Asymmetry adjacent to the collagen-like domain in rat liver mannose- binding protein
62. Structural similarity between lung surfactant protein D and conglutinin. Two distinct, C-type lectins containing collagen-like sequences
63. Structural characteristic and intermolecular organization of human pulmonary-surfactant-associated proteins
64. Comparative study of the structural and functional properties of a bovine plasma C-type lectin, collectin-43, with other collectins
65. Alternate amino terminal processing of surfactant protein A results in cysteinyl isoforms required for multimer formation
66. Structural comparison of recombinant pulmonary surfactant protein SP-A derived from two human coding sequences: Implications for the chain composition of natural human SP-A
67. A parallel three stranded alpha-helical bundle at the nucleation site of collagen triple-helix formation
68. Human mannose-binding protein carbohydrate recognition domain trimerizes through a triple alpha-helical coiled-coil
69. Trimeric structure of a C-type mannose-binding protein
70. Molecular structure of pulmonary surfactant protein D (SP-D)
71. Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36. Structural homology with the complement factor Clq
72. Recombinant pulmonary surfactant protein D. Post-translational modification and molecular assembly
73. Ultra-structure and composition of bovine conglutinin
74. Biochemical and ultrastructural studies of the C-type lectin bovine conglutinin
75. Biosynthesis of surfactant protein D. Contributions of conserved NH2- terminal cysteine residues and collagen helix formation to assembly and secretion
76. Differentiation of conglutination activity and sugar-binding activity of conglutinin after removal of NH2-terminal 54 amino acid residues by endogenous serine protease(s)
77. Collectin in a non-mammalian species: Isolation and characterization of mannan-binding protein (MBP) from chicken serum
78. Assignment of the human pulmonary surfactant protein D gene (SFTP4) to 10q22-q23 close to the surfactant protein A gene cluster
79. Genomic organization of human surfactant protein D (SP-D). SP-D is encoded on chromosome 10q22.2-23.1
80. The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10
81. The coding sequence for the 32.000-dalton pulmonary surfactant-associated protein A is located on chromosone 10 and identifies two separate restriction-fragment-length polymorphisms
82. The 35 kd pulmonary surfactant-associated protein is encoded on chromosome 10
83. Organization of the Human SP-A and SP-D Loci at 10q22-q23. Physical and radiation hybrid mapping reveal gene order and orientation physical and radiation hybrid mapping reveal gene order and orientation
84. Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein
85. Characterization of mRNA transcripts and organization of human SP-A1 and SP-A2 genes
86. Isolation and characterization of the human pulmonary surfactant apoprotein gene
87. Translation in vivo of 5' untranslated-region splice variants of human surfactant protein-A
88. Genomic organisation of the mouse gene for lung surfactant protein D (Sftp4)
89. Chromosomal localization of three pulmonary surfactant protein genes in the mouse
90. The murine mannose-binding protein genes (Mbl 1 and Mbl 2) localize to chromosomes 14 and 19
91. Characterization of murine mannose-binding protein genes Mb11 and Mb12 reveals features common to other collectin genes
92. Somatic cell mapping of conglutinin (CGN1) to cattle syntenic group U29 and fluorescence in situ localization to Chromosome 28
93. Gene organization and 5'-flanking region sequence of conglutinin: A C-type mammalian lectin containing a collagen-like domain
94. Isolation and characterization of the human pulmonary surfactant apoprotein gene
95. Bovine conglutinin gene exon structure reveals its evolutionary relationship to surfactant protein-D
96. Exon structure of a mannose-binding protein gene reflects its evolutionary relationship to the asialoglycoprotein receptor and nonfibrillar collagens
97. Characterization of rat liver mannan-binding protein gene
98. A portion of the human surfactant protein A (SP-A) gene locus consists of a pseudogene
99. An allelic variant of the 6A gene for human surfactant protein A
100. Purification and characterization of two mannan-binding lectins from mouse serum
101. The human ortholog of rhesus mannose-binding protein-A gene is an expressed pseudogene that localizes to chromosome 10
102. Isolation and characterization of porcine mannan-binding proteins of different size and ultrastructure
103. Synthesis of surfactant-associated glycoprotein A by rat type II cells. Primary translation products and post-translational modifications
104. Primary translation product, biosynthesis, and tissue specificity of the major surfactant protein in rat
105. Immunocytochemical localization of the major surfactant apoprotein in type II cells, clare cells, and alveolar macrophages of rat lung
106. Localization of surfactant protein synthesis in human lungs by in situ hybridization
107. Surfactant protein D: Subcellular localization in nonciliated bronchiolar epithelial cells
108. Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lung
109. Developmental expression of SP-A and SP-A mRNA in the proximal and distal respiratory epithelium in the human fetus and newborn
110. Expression of pulmonary surfactant protein D in rat gastric mucosa
111. Pulmonary surfactant protein A (SP-A) is expressed by epithelial cells of small and large intestine
112. Surfactant protein A and lamellar bodies: A homologous secretory function of peritoneum, synovium, and lung
113. Renal expression of serum-type mannan-binding protein in rat
114. Tissue localization of conglutinin, a bovine C-type lectin
115. Post-translational modifications of the core-specific lectin. Relationship to assembly, ligand binding, and secretion
116. The structure and function of surfactant protein A. Hydroxyproline- and carbohydrate-deficient mutant proteins
117. Post-translational processing of procollagens
118. Post-translational modifications of the major human surfactant-associated proteins
119. Glycosylation and secretion of surfactant-associated glycoprotein A
120. Biosynthesis of Surfactant Protein D
121. Regulation of surfactant protein D in human fetal lung
122. An immunohistochemical study of bronchial cells producing surfactant protein A in the developing human fetal lung
123. Surfactant proteins A (SP-A) and D (SP-D): Levels in human amniotic fluid and localization in the fetal membranes
124. Two-site 'simultaneous' immunoassay with monoclonal antibodies for the determination of surfactant apoproteins in human amniotic fluid
125. Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturity
126. Regulation of pulmonary surfactant apoprotein SP 28-36 gene in fetal human lung
127. Induction of surfactant protein in fetal lung. Effect of cAMP and dexamethasone on SAP-35 and synthesis
128. Glucocorticoids both stimulate and inhibit production of pulmonary surfactant protein A in fetal human lung
129. Biphasic glucocorticoid regulation of pulmonary SP-A: Characterization of inhibitory process
130. Regulation of expression of the gene encoding the major surfactant protein (SP-A) in human fetal lung in vitro. Disparate effects of glucocorticoids on transcription and on mRNA stability
131. Regulation of the synthesis of the major surfactant apoprotein in fetal rabbit lung tissue
132. Differential effect of epidermal growth factor and transforming growth factor-β on synthesis of Mr = 35,000 surfactant-associated protein in fetal lung
133. Insulin regulation of messenger ribonucleic acid for the surfactant- associated proteins in human fetal lung in vitro
134. Insulin inhibits the accumulation of the major lung surfactant apoprotein in human fetal lung explants maintained in vitro
135. Phorbol ester inhibits surfactant protein SP-A and SP-B expression
136. Transcriptional regulation of surfactant proteins SP-A and SP-B by phorbol ester
137. Human mannose-binding protein gene is regulated by interleukins, dexamethasone and heat shock
138. Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein
139. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response
140. The complement-activation protease P100 is expressed by hepatocytes and is induced by IL-6 in vitro and during the acute phase reaction in vivo
141. Surfactant protein D. Increased accumulation in silica-induced pulmonary lipoproteinosis
142. Characterization of pulmonary surfactant protein D: Its copurification with lipids
143. Surfactant proteins A and D increase in response to intratracheal lipopolysaccharide
144. Collectin-mediated antiviral host defense of the lung: Evidence from influenza virus infection of mice
145. Les phenomenes d'absorption de la conglutinine du serum de boeuf
146. Conglutination: Specific inhibition by carbohydrates
147. Role of cations in conglutination and in formation of properdin zymosan complex from bovine serum
148. The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein
149. Studies on the carbohydrate-binding characteristics of human pulmonary surfactant-associated protein A and comparison with two other collectins: Mannan-binding protein and conglutinin
150. Surfactant protein D is a divalent cation-dependent carbohydrate-binding protein
151. Differential recognition of core and terminal portions of oligosaccharide ligands by carbohydrate-recognition domains of two mannose-binding proteins
152. Lectins: An overview
153. Specificity of lung surfactant protein SP-A for both the carbohydrate and the lipid moieties of certain neutral glycolipids
154. Collectin-43 is a serum lectin with a distinct pattern of carbohydrate recognition
155. Neoglycolipids as probes of oligosaccharide recognition by recombinant and natural mannose-binding proteins of the rat and man
156. Difference in the binding mode of two mannose-binding proteins: Demonstration of a selective minicluster effect
157. Structural analysis of monosaccharide recognition by rat liver mannose-binding protein
158. A library of oligosaccharide probes (neoglycolipids) from N- glycosylated proteins reveals that conglutinin binds to certain complex-type as well as high mannose-type oligosaccharide chains
159. Binding of sugar ligands to Ca(2+)-dependent animal lectins. I. Analysis of mannose binding by site-directed mutagenesis and NMR
160. Isolation and characterization of a mannan-binding protein from rat liver
161. Isolation and characterization of a mannan-binding protein from human serum
162. Purification and characterization of the core-specific lectin from human serum and liver
163. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A
164. Engineering galactose-binding activity into a C-type mannose-binding protein
165. Binding of sugar ligands to Ca(2+)-dependent animal lectins. II. Generation of high-affinity galactose binding by site-directed mutagenesis
166. Surfactant protein A amino acids Glu195 and Arg197 are essential for receptor binding, phospholipid aggregation, regulation of secretion, and the facilitated uptake of phospholipid by type II cells
167. Epitope mapping for monoclonal antibodies identifies functional domains of pulmonary surfactant protein A that interact with lipids
168. Altered carbohydrate recognition specificity engineered into surfactant protein D reveals different binding mechanisms for phosphatidylinositol and glucosylceramide
169. The demonstration in human serum of 'conglutinin activation factor' and its effect on the third complement component
170. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c
171. Structural analysis of the asparagine-linked oligosaccharides of human complement component C3
172. Localization of the conglutinin binding site on the third component of human complement
173. Differential recognition by conglutinin and mannan-binding protein of N-glycans presented on neoglycolipids and glycoproteins with special reference to complement glycoprotein C3 and ribonuclease B
174. Differentiation of conglutination activity and sugar-binding activity of conglutinin after removal of NH2-terminal 54 amino acid residues by endogenous serine protease(s)
175. Expression of the carbohydrate recognition domain of bovine conglutinin and demonstration of its binding to iC3b and yeast mannan
176. Pulmonary surfactant protein A (SP-A) specifically binds dipalmitoylphosphatidylcholine
177. Pulmonary surfactant protein D specifically binds to phosphatidylinositol
178. The major glucolipid recognized by SP-D in surfactant is phosphatidylinositol
179. A novel type of binding specificity to phospholipids for rat mannose-binding proteins isolated from serum and liver
180. Surfactant protein D
181. Ca(2+)-dependent binding of annexin IV to surfactant protein A and lamellar bodies in alveolar type II cells
182. Interaction of surfactant protein A with cellular myosin
183. A unique CD45 glycoform recognized by the serum mannan-binding protein in immature thymocytes
184. Altered surfactant function and structure in SP-A gene targeted mice
185. Surfactant metabolism in surfactant protein A-deficient mice
186. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection
187. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo
188. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D
189. The conglutination phenomenon. XIII. In Vivo interactions of conglutinin and experimental bacterial infection
190. The conglutination phenomenon. XIV. The resistance enhancing effect of conglutinin and immuno-conglutinin in experimental bacterial infections
191. In vivo and in vitro antibacterial activity of conglutinin, a mammalian plasma lectin
192. Serum lectin with known structure activates complement through the classical pathway
193. A serum lectin (mannan-binding protein) has complement-dependent bactericidal activity
194. The human mannose-binding protein functions as an opsonin
195. Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella
196. Truncated forms of mannose-binding protein multimerize and bind to mannose-rich Salmonella montevideo but fail to activate complement in vitro
197. Binding of mannan-binding protein to various bacterial pathogens of meningitis
198. Interactions of human mannose-binding protein with lipoteichoic acids
199. Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage
200. Expression of the carbohydrate recognition domain of lung surfactant protein D and demonstration of its binding to lipopolysaccharides of gram-negative bacteria
201. Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides
202. Opsonic activities of surfactant proteins A and D in phagocytosis of gram-negative bacteria by alveolar macrophages
203. Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages
204. Aggregation and opsonization of type A but not type B Hemophilus influenzae by surfactant protein A
205. Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages
206. Role of surfactant protein A in the pathogenesis of tuberculosis in subjects with human immunodeficiency virus infection
207. Surfactant protein a promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus
208. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages
209. Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages
210. Inhibitory and inactivating action of normal ferret sera against an influenza virus strain
211. Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins
212. Human mannose-binding protein functions as an opsonin for influenza A viruses
213. Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin
214. Mechanisms of anti-influenza activity of surfactant proteins A and D: Comparison with serum collectins
215. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses
216. Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A
217. Neutrophil deactivation by influenza A viruses: Mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies
218. Interactions of surfactant protein A with influenza A viruses: Binding and neutralization
219. Two distinct serum mannose-binding lectins function as beta inhibitors of influenza virus: Identification of bovine serum beta inhibitor as conglutinin
220. Isolation and characterization of conglutinin as an influenza A virus inhibitor
221. Conglutinin acts as an opsonin for influenza A viruses
222. Antiviral activity of bovine collectins against rotaviruses
223. A serum mannose-binding lectin mediates complement-dependent lysis of influenza virus-infected cells
224. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages
225. Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice
226. Binding of human collectins (SP-A and MBP) to influenza virus
227. Role of envelope glycoprotein carbohydrate in human immunodeficiency virus infectivity and virus induced cell fusion
228. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus
229. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins
230. Mannan-binding protein and bovine conglutinin mediate enhancement of herpes simplex virus type 2 infection in mice
231. Binding of surfactant protein A (SP-A) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A
232. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages
233. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages
234. The carbohydrate recognition domain of surfactant protein A mediates binding to the major surface glycoprotein of Pneumocystis carinii
235. Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: Human surfactant protein D acts as an agglutinin for acapsular yeast cells
236. Effect of mannose-binding protein on binding of Cryptococcus neoformans to human phagocytes
237. Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages
238. Recognition of the major cell surface glycoconjugates of Leishmania parasites by the human serum mannan-binding protein
239. Secreted proteophosphoglycan of Leishmania mexicana amastigotes activates complement by triggering the mannan binding lectin pathway
240. Trypanosoma cruzi amastigote adhesion to macrophages is facilitated by the mannose receptor
241. The major surface glycoprotein of Trypanosoma cruzi amastigotes are ligands of the human serum mannose-binding protein
242. Complement component Cl and the collectins: Parallels between routes of acquired and innate immunity
243. The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein
244. Activation of the classical complement pathway by mannose-binding protein in association with a novel Cls-like serine protease
245. A second serine protease associated with mannan-binding lectin that activates complement
246. Improvements on the purification of mannan-binding lectin and demonstration of its Ca(2+)-independent association with a Cls-like serine protease
247. Activation of the C4 and C2 components of complement by a proteinase in serum bactericidal factor, Ra reactive factor
248. Substrate specificities of the protease of mouse serum Ra-reactive factor
249. Alpha 2-macroglobulin binds to and inhibits mannose-binding protein- associated serine protease
250. Mannan-binding protein forms complexes with alpha-2-macroglobulin. A protein model for the interaction
251. Cleavage of the third component of complement (C3) by mannose-binding protein-associated serine protease (MASP) with subsequent complement activation
252. A 100-kDa protein in the C4-activating component of Ra-reactive factor is a new serine protease having module organization similar to Clr and Cls
253. A new member of the Cls family of complement proteins found in a bactericidal factor, Ra-reactive factor, in human serum
254. Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein
255. Two lineages of mannose-binding lectin-associated serine protease (MASP) in vertebrates
256. Ancient origin of the complement lectin pathway revealed by molecular cloning of mannan binding protein-associated serine protease from a urochordate, the Japanese ascidian, Halocynthia roretzi
257. Exon structure of the gene encoding the human mannose-binding protein-associated serine protease light chain: Comparison with complement Clr and Cls genes
258. Localization of the genes for the 100-kDa complement-activation component of Ra-reactive factor (CRAF and Craf) to human 3q27-q28 and moouse 16B2-B3
259. Human genes for complement components Clr and Cls in a close tail-to-tail arrangement
260. Complement genes Clr and Cls feature an intronless serine protease domain closely related to haptoglobin
261. Assignment of the complement serine protease genes Clr and Cls to chromosome 12 region 12p13
262. Mannan-binding protein, a complement activating animal lectin
263. Properties of a new complement-dependent bactericidal factor specific for Ra chemotype salmonella in sera of conventional and germ-free mice
264. Physicochemical properties of a new bactericidal factor, Ra-reactive factor
265. A new complement-dependent bactericidal factor found in nonimmune mouse sera: Specific binding to polysaccharide of Ra chemotype Salmonella
266. The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor
267. The 28k and 70k dalton polypeptide components of mouse Ra- reactive factor are responsible for bactericidal activity
268. Major component of Ra-reactive factor, a complement-activating bactericidal protein, in mouse serum
269. Human mannose-binding protein is identical to a component of Ra-reactive factor
270. A group of bactericidal factors conserved by vertebrates for more than 300 million years
271. Complement-dependent cytotoxic activity of serum mannan-binding protein towards mammalian cells with surface-exposed high-mannose type glycans
272. Mannose-binding protein recognizes glioma cells: In vitro analysis of complement activation on glioma cells via the lectin pathway
273. Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: Mannan-binding proteindependent cell-mediated cytotoxicity
274. Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production
275. Surfactant protein A regulates cytokine production in the monocytic cell line THP-1
276. Interaction of surfactant protein A with bacterial lipopolysaccharide may affect some biological functions
277. Effect of SP-A and surfactant lipids on expression of cell surface markers in the THP-1 monocytic cell line
278. Surfactant protein A activates NF-kappa B in the THP-1 monocytic cell line
279. Recombinant rat surfactant-associated protein D inhibits human T. lymphocyte proliferation and IL-2 production
280. Interactions of pulmonary surfactant protein D (SP-D) with human blood leukocytes
281. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages
282. Recombinant SP-D carbohydrate recognition domain is a chemoattractant for human neutrophils
283. Rat surfactant protein D enhances the production of oxygen radicals by rat alveolar macrophages
284. Conglutinin exhibits a complement-dependent enhancement of the respiratory burst of phagocytes stimulated by E. coli
285. Surfactant protein D: Possible role in pulmonary host defence
286. Surfactant protein A
287. Binding of surfactant protein A to Clq receptors mediates phagocytosis of Staphylococcus aureus by monocytes
288. Molecular structures and interactions of pulmonary surfactant components
289. Identification of the Raji cell membrane-derived Clq inhibitor as a receptor for human Clq. Purification and immunochemical characterization
290. Functional aspects of the Clq receptors
291. Human leukocyte Clq receptor binds other soluble proteins with collagen domains
292. Interaction of Clq receptor with lung surfactant protein A
293. Localization of the receptor-binding site in the collectin family of proteins
294. Structure and homology of human Clq receptor (collectin receptor)
295. Calreticulin is released from activated neutrophils and binds to Clq and mannan-binding protein
296. Localisation of the Clq binding site within Clq receptor/calreticulin
297. The Clq and collectin binding site within Clq receptor (cell surface calreticulin)
298. Identification of a gClq-binding protein (gClq-R) on the surface of human neutrophils. Subcellular localization and binding properties in comparison with the cClq-R
299. Modulation of FcR function by complement: Subcomponent Clq enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages
300. Human pulmonary surfactant protein (SP-A), a protein structurally homologous to Clq, can enhance FcR- and CRl-mediated phagocytosis
301. Mannose binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 M(r) component of the Clq receptor
302. Clq enhances the phagocytosis of Cryptococcus neoformans blastospores by human monocytes
303. Phagocytic cell molecules that bind the collagen-like region of Clq. Involvement in the Clq-mediated enhancement of phagocytosis
304. Cell-surface protein identified on phagocytic cells modulates the Clq- mediated enhancement of phagocytosis
305. cDNA cloning and primary structure analysis of ClqR(P), the human Clq/MBL/SPA receptor that mediates enhanced phagocytosis in vitro
306. ClqRP, the Clq receptor that enhances phagocytosis, is detected specifically in human cells of myeloid lineage, endothelial cells, and platelets
307. Complement receptor type 1 (CR1, CD35) is a receptor for Clq
308. Purification of a cell-surface receptor for surfactant protein A
309. SP-A enhances uptake of bacillus Calmette-Guerin by macrophages through a specific SP-A receptor
310. Surfactant protein A-binding proteins. Characterization and structures
311. Applications of anti-Curosurf antibodies to understanding the biology of alveolar surfactant
312. Receptor-mediated regulation of pulmonary surfactant secretion
313. Identification of a new surfactant protein A binding protein at the cell membrane of rat type II pneumocytes
314. SP-A-binding protein BP55 is involved in surfactant endocytosis by type II pneumocytes
315. Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule
316. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours
317. CRP-ductin: A gene expressed in intestinal crypts and in pancreas and hepatic ducts
318. Molecular cloning of Ebnerin, a von Ebner's gland protein associated with taste buds
319. A familial, plasma-associated defect of phagocytosis. A new cause of recurrent bacterial infections
320. Defective opsonization. A common immunity deficiency
321. Yeast opsonisation in children with chronic diarrhoeal states
322. Defective yeast opsonization and C2 deficiency in atopic patients
323. A common congenital immunodeficiency predisposing to infection and atopy in infancy
324. A rapid objective method for measuring the yeast opsonisation activity of serum
325. The effect of C3 levels on yeast opsonization by normal and pathological sera: Identification of a complement independent opsonin
326. Association of low levels of mannan-binding protein with a common defect of opsonisation
327. Molecular basis of opsonic defect in immunodeficient children
328. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene
329. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein
330. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein
331. Deficiency of mannan binding protein - A new complement deficiency syndrome
332. Distinct and overlapping functions of allelic forms of human mannose binding protein
333. Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype
334. Role of the collagen-like domain of the human serum mannan-binding protein in the activation of complement and the secretion of this lectin
335. The Gly-54- > Asp allelic form of human mannose-binding protein (MBP) fails to bind MBP-associated serine protease
336. Mutations in the human mannose-binding protein gene: Frequencies in several population groups
337. Mannan binding lectin deficiency and concomitant immunodefects
338. Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection
339. Mannan-binding protein-levels in plasma and upper-airways secretions and frequency of genotypes in children with recurrence of otitis media
340. A low serum concentration of mannan-binding protein is not associated with serogroup B or C meningococcal disease
341. Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency
342. Mannose binding protein gene mutations associated with unusual and severe infections in adults
343. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin
344. Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics
345. The level of the serum opsonin, mannan-binding protein in HIV-1 antibody-positive patients
346. Mannan-binding lectin serum concentrations in HIV-infected patients are influenced by the stage of disease
347. Contribution of the CCR5 and MBL genes to susceptibility to HIV type 1 infection in the Finnish population
348. Association of mannose-binding-lectin deficiency with severe atherosclerosis
349. Association between mannan binding protein deficiency and recurrent miscarriage
350. Mannan-binding lectin in human serum, cerebrospinal fluid and brain tissue and its role in Alzheimer's disease
351. Inherited deficiencies of complement proteins with special reference to congenital deficiency of the regulatory protein factor I
352. Mannan binding lectin in rheumatoid arthritis. A longitudinal study
353. Absence of an association between mannose-binding lectin polymorphism and rheumatoid arthritis
354. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein
355. Mannose-binding protein gene polymorphism in systemic lupus erythematosus
356. A dysfunctional allele of the mannose binding protein gene associates with systemic lupus erythematosus in a Spanish population
357. Mannose-binding protein in Chinese patients with systemic lupus erythematosus
358. Effect of genotype on the levels of surfactant protein A mRNA and on the SP-A2 splice variants in adult humans
359. Surfactant proteins: Molecular genetics of neonatal pulmonary diseases
360. Association of pulmonary surfactant protein A (SP-A) gene and respiratory distress syndrome: Interaction with SP-B
361. Premature delivery of foetal lambs infused with glucocorticoids
362. Metabolism and turnover of lung surfactant
363. Increases in the 35 kDa surfactant-associated protein and its mRNA following in vivo dexamethasone treatment of fetal and neonatal rats
364. Surfactant apoprotein A (SP-A) in tracheal aspirates of newborn infants with RDS
365. Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome
366. Decreased surfactant protein A in patients with bacterial pneumonia
367. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema
368. Surfactant composition in infants and young children with cystic fibrosis
369. Increased recovery of surfactant protein A in AIDS-related pneumonia
370. Accumulation of surfactant protein D in the lung during Pneumocystis carinii pneumonia
371. Pneumocystis carinii alters surfactant protein A concentrations in bronchoalveolar lavage fluid
372. Increased recovery of surfactant protein A in AIDS-related pneumonia
373. Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat
374. Effects of cigarette smoking on the serum concentration of lung surfactant protein A (SP-A)
375. Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis
376. Studien uber die Konglutination und uber das Schwaken des Konglutingehaltes im Serum gesunder und kranker Rinder
377. Conglutinin level in dairy cattle: Changes associated with disease
378. Serum levels of conglutinin, complement, and immunoconglutinin in cattle infected with Anaplasma marginale
379. The natural resistance of cattle to artificial infection with Cowdria ruminantium: The role played by conglutinin
380. Conglutinin levels in dairy cattle: Changes associated with parturition
381. Immune complexes associated with infection of cattle by the herpesvirus of malignant catarrhal fever
382. The plasma level of conglutinin are heritable and low levels predispose to infection in cattle
383. Pollen grains bind to lung alveolar type II cells (A549) via lung surfactant protein A (SP-A)
384. Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens
385. Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils